| AXP |
Report |
Diluted EPS |
BEAT |
pred ~$4.48 vs. cons $4.41 |
MEDIUM |
| AXP |
Report |
Revenue, net of interest expense |
IN-LINE |
pred ~$19.82B vs. cons $19.70B |
MEDIUM |
| AXP |
Report |
FX-adjusted billed-business growth |
IN-LINE |
pred ~9.0% vs. cons 9.0% |
MEDIUM |
| AXP |
Guide |
Revenue growth guidance |
UNCHANGED |
guide ~9%-10% vs. cons 9.8% (FY2026) |
HIGH |
| AXP |
Guide |
Diluted EPS guidance |
UNCHANGED |
guide ~$17.30-$17.90 vs. cons $17.65 (FY2026) |
HIGH |
| AXP |
Guide |
Variable customer engagement cost-to-revenue ratio |
UNCHANGED |
guide ~44.0% vs. cons 44.0% (FY2026) |
MEDIUM |
| AXP |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.4% |
— |
MEDIUM |
| AXP |
Return |
5-day cumulative residual |
-3.2% (FOLLOW-THROUGH) |
A modest Q2 EPS beat of ~$4.48 vs. $4.41 is unlikely to offset unchanged FY2026 guidance centered at ~$17.60 vs. consensus $17.65. Holding the annual range after first-half upside implies lower second-half earnings expectations as incremental marketing, technology and benefit costs absorb operating strength, driving negative estimate revisions and follow-through. |
MEDIUM |